Global Seizure Detection Device Market Overview:
Seizures are symptoms of various disorders such as epilepsy, brain disorders, and neurological disorders. Basically Seizures are referred to as sudden, uncontrolled electrical changes in the brain which leads to changes in behavior that are not considered normal also affect consciousness and feelings. There are different types of seizures, which differ according to their severity. Various detection devices are available in the market according to their types and specification. They are precisely available different for adults and children. Some of the key players profiled in the study are Koninklijke Philips N.V (Netherlands), Empatica (United States), Nihon Kohden (Japan), Medtronic (Ireland), Boston Scientific (United States), Natus (United States), Abbott (United States), Compumedic (Australia), LivaNova Plc (United Kingdom), Emotiv (United States) and NeuroPace, Inc (United States).
On the basis of geography, the market of Seizure Detection Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Patient Type, the sub-segment i.e. Toddler will boost the Seizure Detection Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Specifications, the sub-segment i.e. Mattress devices will boost the Seizure Detection Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Seizure Detection Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Awareness Related To Mental Illness And Its Detection
- Increasing Brain Related And Neurological Disorders
- Easy To Use Wearable Devices Are Available
- Weight Restriction Is One Of the Disadvantages In Some Devices
- Growing Treatments And Therapies Related To Seizures And Epilepsy
- High Cost Associated With Product
- Stringent Regulatory Policies
Major Market Developments:
On 19th February 2020, Abbott will combine with Insuletís Omnipod horizon to enhance next-generation glucose sensing and automated insulin delivery technologies for seamless diabetes care. The collaboration will advance the diabetic care unit of the company and add more service to consumers; it will serve people at an affordable rate for improving glucose control.
On 13th December 2019, Boston Scientific Corporation announced US Food and drug administration (FDA) approved 510(k) clearance for EXALT Model D Single-Use Duodenoscope. It is first and only FDA cleared single-use (disposable) duodenoscope on the market and was granted.
On 8th January 2019, Empatica has received 510(k) clearance from FDA for its Embrace2, a seizure monitoring wearable device for children which will help to detect the patterns in motion and physiological signals that may be associated with generalized tonic-clonic seizures, and immediately alerts caregivers. The device will only available after the generation of prescriptions.
The growing market for detection devices for accessing early treatments and it is one of the reasons increasing demand for seizure detection devices in the market. Therefore top leading firms coming with the technologically enhanced products to compete with each other. The strategical changes may occur due to acquisitions and mergers in the market which will lead to a rivalry between top firms.
Manufacturers of Seizure diagnostics equipment, Research associations related to Seizure/Epilepsy diagnostics, Psychologist and Psychologist Clinics, Various research and consulting firms, Distributors of Seizure/Epilepsy diagnostics equipment and Government bodies and Regulatory Bodies
Major Objectives Focused through this Study
To define, describe, and forecast the Global Seizure Detection Device market on the basis of product [Conventional Seizure Detection Devices, Wearable Seizure Detection Devices, Implantable Seizure Detection Devices and Others (EEG machine, electromyography machine, Magnetic resonance imaging (MRI) device, Computed tomography device, and novel devices)] , application [Diagnosis of Seizure/Epilepsy and Monitoring Seizure/Epilepsy], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Seizure Detection Device market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Seizure Detection Device industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Seizure Detection Device market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.